+
Open data
-
Basic information
Entry | Database: PDB / ID: 9bdt | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Title | Apolipoprotein B 100 bound to LDL receptor and legobody | ||||||||||||||||||||||||
![]() |
| ||||||||||||||||||||||||
![]() | LIPID TRANSPORT / LDL / ApoB100 / LDL receptor | ||||||||||||||||||||||||
Function / homology | ![]() mature chylomicron / Scavenging by Class H Receptors / triglyceride mobilization / positive regulation of cholesterol storage / VLDL assembly / regulation of cholesterol biosynthetic process / receptor-mediated endocytosis involved in cholesterol transport / regulation of phosphatidylcholine catabolic process / lipase binding / plasma lipoprotein particle clearance ...mature chylomicron / Scavenging by Class H Receptors / triglyceride mobilization / positive regulation of cholesterol storage / VLDL assembly / regulation of cholesterol biosynthetic process / receptor-mediated endocytosis involved in cholesterol transport / regulation of phosphatidylcholine catabolic process / lipase binding / plasma lipoprotein particle clearance / LDL remodeling / Scavenging by Class B Receptors / positive regulation of lysosomal protein catabolic process / negative regulation of astrocyte activation / VLDL clearance / triglyceride catabolic process / negative regulation of microglial cell activation / very-low-density lipoprotein particle assembly / very-low-density lipoprotein particle receptor activity / PCSK9-LDLR complex / cholesterol import / low-density lipoprotein particle clearance / clathrin heavy chain binding / negative regulation of receptor recycling / positive regulation of triglyceride biosynthetic process / intestinal cholesterol absorption / negative regulation of low-density lipoprotein particle clearance / chylomicron remnant / intermediate-density lipoprotein particle / low-density lipoprotein particle receptor activity / response to caloric restriction / Chylomicron clearance / low-density lipoprotein particle binding / amyloid-beta clearance by cellular catabolic process / Chylomicron remodeling / cellular response to lipoprotein particle stimulus / regulation of protein metabolic process / Chylomicron assembly / LDL clearance / flagellated sperm motility / Regulation of TLR by endogenous ligand / positive regulation of lipid storage / high-density lipoprotein particle clearance / chylomicron / lipoprotein catabolic process / phospholipid transport / low-density lipoprotein particle / lipoprotein biosynthetic process / cholesterol transfer activity / cholesterol transport / very-low-density lipoprotein particle / low-density lipoprotein particle remodeling / endolysosome membrane / positive regulation of macrophage derived foam cell differentiation / negative regulation of amyloid fibril formation / fertilization / IgG binding / cholesterol efflux / regulation of cholesterol metabolic process / negative regulation of protein metabolic process / artery morphogenesis / lipoprotein transport / Scavenging by Class A Receptors / cellular response to fatty acid / low-density lipoprotein particle receptor binding / Scavenging by Class F Receptors / Platelet sensitization by LDL / sorting endosome / amyloid-beta clearance / lipoprotein particle binding / endoplasmic reticulum exit site / cellular response to low-density lipoprotein particle stimulus / carbohydrate transmembrane transporter activity / maltose binding / maltose transport / long-term memory / maltodextrin transmembrane transport / smooth endoplasmic reticulum / phagocytosis / Retinoid metabolism and transport / ATP-binding cassette (ABC) transporter complex, substrate-binding subunit-containing / clathrin-coated pit / somatodendritic compartment / lipid droplet / endocytic vesicle lumen / receptor-mediated endocytosis / cholesterol metabolic process / lysosomal lumen / cholesterol homeostasis / post-embryonic development / endosome lumen / Cell surface interactions at the vascular wall / establishment of localization in cell / Post-translational protein phosphorylation / clathrin-coated endocytic vesicle membrane / Heme signaling / response to virus / phospholipid binding / lipid metabolic process / positive regulation of inflammatory response Similarity search - Function | ||||||||||||||||||||||||
Biological species | ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | ||||||||||||||||||||||||
Method | ELECTRON MICROSCOPY / single particle reconstruction / cryo EM / Resolution: 5.4 Å | ||||||||||||||||||||||||
![]() | Dearborn, A.D. / Reimund, M. / Graziano, G. / Lei, H. / Kumar, A. / Neufeld, E.B. / Remaley, A.T. / Marcotrigiano, J. | ||||||||||||||||||||||||
Funding support | ![]()
| ||||||||||||||||||||||||
![]() | ![]() Title: Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor. Authors: Mart Reimund / Altaira D Dearborn / Giorgio Graziano / Haotian Lei / Anthony M Ciancone / Ashish Kumar / Ronald Holewinski / Edward B Neufeld / Francis J O'Reilly / Alan T Remaley / Joseph Marcotrigiano / ![]() Abstract: Apolipoprotein B100 (apoB100) is a structural component of low-density lipoprotein (LDL) and a ligand for the LDL receptor (LDLR). Mutations in apoB100 or in LDLR cause familial ...Apolipoprotein B100 (apoB100) is a structural component of low-density lipoprotein (LDL) and a ligand for the LDL receptor (LDLR). Mutations in apoB100 or in LDLR cause familial hypercholesterolaemia, an autosomal dominant disease that is characterized by a marked increase in LDL cholesterol (LDL-C) and a higher risk of cardiovascular disease. The structure of apoB100 on LDL and its interaction with LDLR are poorly understood. Here we present the cryo-electron microscopy structures of apoB100 on LDL bound to the LDLR and a nanobody complex, which can form a C-symmetric, higher-order complex. Using local refinement, we determined high-resolution structures of the interfaces between apoB100 and LDLR. One binding interface is formed between several small-ligand-binding modules of LDLR and a series of basic patches that are scattered along a β-belt formed by apoB100, encircling LDL. The other binding interface is formed between the β-propeller domain of LDLR and the N-terminal domain of apoB100. Our results reveal how both interfaces are involved in LDL dimer formation, and how LDLR cycles between LDL- and self-bound conformations. In addition, known mutations in either apoB100 or LDLR, associated with high levels of LDL-C, are located at the LDL-LDLR interface. | ||||||||||||||||||||||||
History |
|
-
Structure visualization
Structure viewer | Molecule: ![]() ![]() |
---|
-
Downloads & links
-
Download
PDBx/mmCIF format | ![]() | 922.9 KB | Display | ![]() |
---|---|---|---|---|
PDB format | ![]() | Display | ![]() | |
PDBx/mmJSON format | ![]() | Tree view | ![]() | |
Others | ![]() |
-Validation report
Summary document | ![]() | 1.3 MB | Display | ![]() |
---|---|---|---|---|
Full document | ![]() | 1.5 MB | Display | |
Data in XML | ![]() | 165.3 KB | Display | |
Data in CIF | ![]() | 245.5 KB | Display | |
Arichive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
Related structure data | ![]() 44469MC ![]() 9bd1C ![]() 9bd8C ![]() 9bdeC ![]() 9cooC M: map data used to model this data C: citing same article ( |
---|---|
Similar structure data | Similarity search - Function & homology ![]() |
-
Links
-
Assembly
Deposited unit | ![]()
|
---|---|
1 |
|
-
Components
-Protein , 2 types, 3 molecules AIR
#1: Protein | Mass: 516167.469 Da / Num. of mol.: 1 / Source method: isolated from a natural source / Source: (natural) ![]() |
---|---|
#5: Protein | Mass: 95477.023 Da / Num. of mol.: 2 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() |
-Antibody , 4 types, 4 molecules HLBN
#2: Antibody | Mass: 25252.217 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() ![]() |
---|---|
#3: Antibody | Mass: 24095.852 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() |
#4: Antibody | Mass: 59233.246 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() ![]() Gene: malE, malE_1, A9X72_23600, ACN81_05700, ACU57_23670, AM464_13530, B6R31_000964, BANRA_05111, BCB93_001091, BF481_003801, BG944_002391, BGM66_004246, BJI68_06200, BJJ90_24825, BK292_00970, BTB68_ ...Gene: malE, malE_1, A9X72_23600, ACN81_05700, ACU57_23670, AM464_13530, B6R31_000964, BANRA_05111, BCB93_001091, BF481_003801, BG944_002391, BGM66_004246, BJI68_06200, BJJ90_24825, BK292_00970, BTB68_002078, BTQ06_17300, BvCmsKKP061_03224, BvCmsSIP010_04050, C0P57_003867, C1Q91_002164, C2R31_001890, C3F40_15210, C9E67_28370, CA593_05740, CF22_001770, CG692_11710, CG704_16590, CG831_003746, CIG67_12040, CQ986_003892, CR538_23895, CR539_01985, CTR35_003815, CV83915_02005, D4M65_12865, DIV22_28370, DNX30_07695, DS732_01860, DTL43_19585, E4K51_08355, E5H86_20640, E6D34_15030, EAI46_20350, EC95NR1_03574, ECs5017, EIZ93_13775, EN85_000970, EPS97_17355, ExPECSC038_04540, F9407_08085, F9461_21760, FIJ20_18085, FJQ40_13885, FOI11_015465, FOI11_20215, FPS11_04610, FV293_00135, FWK02_22115, G3V95_18070, G4A38_02205, G4A47_04495, G9448_13225, GAI89_05080, GAJ12_13200, GJ11_25475, GKF66_19285, GNW61_17855, GOP25_18965, GP965_07770, GP975_07695, GP979_10140, GQA06_09595, GQM04_22095, GQM21_08325, GRW05_14255, GRW24_12940, GRW56_08975, GRW57_10345, GUC01_08260, H0O72_20100, HEP30_015080, HHH44_003952, HLX92_13085, HMV95_14740, HV109_22180, HV209_20940, HVW43_14700, HVY77_23840, HX086_10250, HX136_23390, I6H00_16895, I6H02_15990, J0541_001933, J5U05_001620, JNP96_01525, KV259_002584, KV317_002918, KV371_002846, KV406_003109, KV449_002737, KV455_002759, KV463_002918, KV469_002607, KV499_002898, KV500_002927, NCTC10418_07064, NCTC10429_00012, NCTC10865_05806, NCTC11126_02082, NCTC11181_01902, NCTC12950_05149, NCTC13148_04480, NCTC4450_01671, NCTC8009_08341, NCTC8179_05034, NCTC8333_05503, NCTC8500_05253, NCTC8622_01707, NCTC8960_02276, NCTC8985_03950, NCTC9706_01951, NCTC9962_03706, NEP60_16880, O5851_07355, RG28_25590, SAMEA3752557_02201, TUM18780_41180, WR15_07725, spa, SA0107, spg Production host: ![]() ![]() References: UniProt: C3SHQ8, UniProt: P99134, UniProt: P06654 |
#6: Antibody | Mass: 14322.896 Da / Num. of mol.: 1 Source method: isolated from a genetically manipulated source Source: (gene. exp.) ![]() ![]() ![]() ![]() |
-Sugars , 2 types, 5 molecules 
#7: Polysaccharide | 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose Source method: isolated from a genetically manipulated source |
---|---|
#8: Sugar | ChemComp-NAG / |
-Non-polymers , 1 types, 7 molecules 
#9: Chemical | ChemComp-CA / |
---|
-Details
Has ligand of interest | N |
---|---|
Has protein modification | Y |
-Experimental details
-Experiment
Experiment | Method: ELECTRON MICROSCOPY |
---|---|
EM experiment | Aggregation state: PARTICLE / 3D reconstruction method: single particle reconstruction |
-
Sample preparation
Component | Name: Apoliprotein B 100 from LDL bound to LDL receptor and Legobody Type: COMPLEX / Entity ID: #2-#6 / Source: NATURAL |
---|---|
Molecular weight | Experimental value: NO |
Source (natural) | Organism: ![]() |
Buffer solution | pH: 7.4 |
Specimen | Embedding applied: NO / Shadowing applied: NO / Staining applied: NO / Vitrification applied: YES |
Specimen support | Grid material: GOLD / Grid mesh size: 300 divisions/in. / Grid type: C-flat-1.2/1.3 |
Vitrification | Instrument: FEI VITROBOT MARK IV / Cryogen name: ETHANE |
-
Electron microscopy imaging
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
---|---|
Microscopy | Model: FEI TITAN KRIOS |
Electron gun | Electron source: ![]() |
Electron lens | Mode: BRIGHT FIELD / Nominal defocus max: 2000 nm / Nominal defocus min: 600 nm |
Image recording | Electron dose: 51.38 e/Å2 / Film or detector model: GATAN K3 BIOCONTINUUM (6k x 4k) |
-
Processing
CTF correction | Type: PHASE FLIPPING AND AMPLITUDE CORRECTION | ||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Particle selection | Num. of particles selected: 3689076 / Details: Selected with Topaz | ||||||||||||||||||||||||
3D reconstruction | Resolution: 5.4 Å / Resolution method: FSC 0.143 CUT-OFF / Num. of particles: 527598 / Symmetry type: POINT | ||||||||||||||||||||||||
Refine LS restraints |
|